Researchers at Stony Brook University, Stony Brook, NY, have developed a device that can be used to optimise cardiovascular device design to eliminate the risk of clot formation.
The device thrombogenicity emulator (DTE) measures the potential that a cardiovascular device will cause a blood clot.
During the Phase I of the project, the researchers developed and tested the device in laboratory models. In the Phase II study, the researchers are planning to use DTE to identify the areas in cardiovascular devices where clots can form.
Lead researcher Danny Bluestein said that within the DTE, it is possible to tweak the geometry of the device's design to optimise it and minimise or eliminate these hot spots.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement
